7WKU

Structure of PDCoV Mpro in complex with an inhibitor

Summary for 7WKU

• Entry DOI: 10.2210/pdb7wku/pdb
• Related PRD ID: PRD_002214
• Descriptor: Peptidase C30, N-[(5-METHYLISOXAZOL-3-YL)CARBONYL]ALANYL-L-VALYL-N~1~-((1R,2Z)-4-(BENZYLOXY)-4-OXO-1-{[(3R)-2-OXOPYRROLIDIN-3-YL]METHYL}BUT-2-ENYL)-L-LEUCINAMIDE (3 entities in total)
• Functional Keywords: virus, viral protease, drug design, inhibitor, broad-spectrum antivirals, viral protein
• Biological source: Porcine deltacoronavirus; More
• Total number of polymer chains: 12
• Total formula weight: 212101.30

Authors

Wang, F.H.,Yang, H.T. (deposition date: 2022-01-11, release date: 2022-05-25, Last modification date: 2024-10-16)

Primary citation

Wang, F.,Chen, C.,Wang, Z.,Han, X.,Shi, P.,Zhou, K.,Liu, X.,Xiao, Y.,Cai, Y.,Huang, J.,Zhang, L.,Yang, H.
The Structure of the Porcine Deltacoronavirus Main Protease Reveals a Conserved Target for the Design of Antivirals.
Viruses, 14:-, 2022

PubMed Abstract: The existing zoonotic coronaviruses (CoVs) and viral genetic variants are important microbiological pathogens that cause severe disease in humans and animals. Currently, no effective broad-spectrum antiviral drugs against existing and emerging CoVs are available. The CoV main protease (M) plays an essential role in viral replication, making it an ideal target for drug development. However, the structure of the M is still unavailable. Porcine deltacoronavirus (PDCoV) is a novel CoV that belongs to the genus and causes atrophic enteritis, severe diarrhea, vomiting and dehydration in pigs. Here, we determined the structure of PDCoV M complexed with a Michael acceptor inhibitor. Structural comparison showed that the backbone of PDCoV M is similar to those of alpha-, beta- and gamma-CoV Ms. The substrate-binding pocket of M is well conserved in the subfamily . In addition, we also observed that Ms from the same genus adopted a similar conformation. Furthermore, the structure of PDCoV M in complex with a Michael acceptor inhibitor revealed the mechanism of its inhibition of PDCoV M. Our results provide a basis for the development of broad-spectrum antivirals against PDCoV and other CoVs.

PubMed: 35336895
DOI: 10.3390/v14030486

Experimental method

X-RAY DIFFRACTION (2.6 Å)